ENDOLUCIN BETA
Live / Registered — Registered — international registration renewed (as of 16 Sept 2024)
What this means for you
Registered since 14 Nov 2017. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 14 Nov 2027: the §71 ten-year affidavit of use).
Record
- Serial number
- 79199839
- Registration number
- 5332068
- Mark type
- Design + words
- Filed
- 14 Oct 2016
- Published for opposition
- 29 Aug 2017
- Registered
- 14 Nov 2017
- Next maintenance filing
- §71 ten-year affidavit of use, due by 14 Nov 2027 (grace period to 14 May 2028)
- Attorney of record
- David M. Kohn
Goods and services
- Class 005 — Pharmaceuticals: Radiopharmaceutical preparations, namely, precursors containing lutetium for therapeutic or diagnostic purposes; Radioactive substances for medical purposes, namely, for radio-labelling pharmaceutical compounds for use in nuclear medicine
Owner
Prosecution history
- 01 Oct 2026 — INTERNATIONAL REGISTRATION RENEWED
- 16 Sept 2024 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 16 Sept 2024 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 18 Jul 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 02 Nov 2023 — TEAS SECTION 71 & 15 RECEIVED
- 14 Nov 2022 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 26 Nov 2021 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 13 Apr 2018 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 20 Feb 2018 — FINAL DISPOSITION NOTICE SENT TO IB
- 20 Feb 2018 — FINAL DISPOSITION PROCESSED
- 14 Feb 2018 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 14 Nov 2017 — REGISTERED-PRINCIPAL REGISTER
- 29 Aug 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Aug 2017 — PUBLISHED FOR OPPOSITION
- 09 Aug 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED